Research progress on tumor immune microenvironment evaluation in efficacy predic-tion / 中国肿瘤临床
Chinese Journal of Clinical Oncology
; (24): 599-603, 2018.
Article
em Zh
| WPRIM
| ID: wpr-706856
Biblioteca responsável:
WPRO
ABSTRACT
With the clinical applications of new immunotherapies, traditional TNM staging has been unable to meet the clinical needs of curative effect predictions. It is known that the immunological features of the tumor immune microenvironment play important roles in tumor prognosis evaluations. Recently, the immunoscore system, which is based on local immune cell distribution and density, has gradually become an important indicator for prognosis evaluations and has been verified in several tumor researches. Recently, with the application of new mass flow detection and single cell sequencing technologies, the number of immune landscape studies have also been increasing, and new tumor-specific immune cell subsets have been identified. These subtypes not only provide individ-ualized immunotherapy guidelines for patients, but also provide potential new targets for the further development of new immuno-therapy strategies. This review will introduce recent research progress in this field.
Texto completo:
1
Índice:
WPRIM
Tipo de estudo:
Guideline
/
Prognostic_studies
Idioma:
Zh
Revista:
Chinese Journal of Clinical Oncology
Ano de publicação:
2018
Tipo de documento:
Article